{
    "2018-11-05": [
        [
            {
                "time": "2018-10-25",
                "original_text": "医药生物行业2018年三季报综述——行业整体收入和扣非利润保持20%的增速中枢",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "收入",
                        "扣非利润",
                        "增速"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "生物医药行业2018年三季报综述：医药2018Q3收入回暖，利润承压，子行业分化加剧",
                "features": {
                    "keywords": [
                        "生物医药",
                        "三季报",
                        "收入回暖",
                        "利润承压",
                        "子行业分化"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "医疗保健：创新升级大势所趋 荐9股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "创新升级",
                        "荐股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "前三季度17家药企净利润超过10亿元",
                "features": {
                    "keywords": [
                        "药企",
                        "净利润",
                        "前三季"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "7家药企全年净利润有望超过30亿元",
                "features": {
                    "keywords": [
                        "药企",
                        "全年净利润",
                        "30亿元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}